entertainment -WSS

entertainment

author：comprehensive 2025-10-01 21:37:45 - browse：895

Two people run on the sugar-phosphate backbone of DNA while holding base pairs — in the lab coverage from STAT — Adobe

LONDON — Widespread genetic testing as well as the development of cutting-edge, customized genetic therapies have opened the door to treating many more inherited conditions than previously possible. A few recent cases, in which bespoke medicines were created for children with exceedingly rare mutations, have raised hopes for furthering the approach.

Now, researchers and government agencies in the U.K. are trying to figure out the nitty-gritty to replicate those early one-off successes for as many patients as possible — what sort of preclinical testing a tailor-made treatment needs to go through before being used, what regulatory thresholds each treatment needs to clear, and how to pay for these therapies.

“A lot of the barriers are no longer scientific — we can make these drugs,” said Matthew Wood, a professor of pediatrics at the University of Oxford. “It’s more about, can we make them at a cost that is reasonable enough? And can we get the regulators to reduce the barriers to doing this so that when a patient shows up, you can actually make a drug quickly enough to benefit that patient, rather than it costing huge amounts of money and taking two or three years to do it?”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： A protest over insulin prices is seen as a fight for life

WSS

Eli Lilly CEO gives to Mike Pence presidential super PAC

340B reform proposal comes out of Senate working group

The Biogen Aduhelm mess could happen again

AstraZeneca stays mum on Medicare drug pricing negotiations

Updated Covid vaccine has 54% effectiveness, new study suggests

Akili changes sales model for its ADHD video game treatment

entertainment

entertainment

focus

How to save PrEP access — and even expand it

Surgery pushed Ben Carson to fame

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Bernie brings in new pharma CEOs to talk drug prices

In age of alternative facts, a scholarly course on calling out crap

Adopting new red light myopia treatments may be short

Activists slam private health insurers over coverage restrictions

340B reform proposal comes out of Senate working group

United colonoscopy coverage change 'may cost lives,' doctors say

Problems with a popular proposal to regulate AI in health care

leisure time

Problems with a popular proposal to regulate AI in health care

Covid’s new normal has set in amid another rise in cases

Patients, doctors press FTC to beef up hospital merger scrutiny

House panel takes first step toward fixing drug shortages

Problems with a popular proposal to regulate AI in health care

Transgender sports debate: Physicians say bans are health issue

explore

Wikipedia

explore

explore